Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

792
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
792
Cancer Survival Analysis01:21

Cancer Survival Analysis

863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Survival Tree01:19

Survival Tree

499
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
499
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Actuarial Approach01:20

Actuarial Approach

384
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
384
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

492
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
492

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of survival outcomes for people with HR+/HER2- metastatic breast cancer who received palbociclib, ribociclib, or abemaciclib with an aromatase inhibitor: a plain language summary.

Future oncology (London, England)·2026
Same author

Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summary.

Future oncology (London, England)·2026
Same author

Survivor Perspectives on Artificial Intelligence Integration in Breast Cancer Treatment: A Qualitative Study of Trust, Equity, and Application.

European journal of breast health·2026
Same author

Phase II Study of Adavosertib in Patients With Tumors Containing BRCA1 and BRCA2 Mutations: Results From the NCI-MATCH ECOG-ACRIN Cancer Research Group (EAY131) Subprotocol Z1I.

JCO precision oncology·2026
Same author

Automated Monkeypox Identification from Electronic Medical Records Using Large Language Models - Shenzhen City, Guangdong Province, China, 2023-2025.

China CDC weekly·2026
Same author

Multi-modal AI for comprehensive breast cancer prognostication.

Nature communications·2026
Same journal

Widening Health Inequality and Causal Metabolic Drivers in Global Colorectal Cancer: A Multi-Dimensional Study.

Cancer informatics·2026
Same journal

GFAP-Dependent Transcriptional Dynamics and Cellular Heterogeneity in Primary, Recurrent, and Grade III Gliomas.

Cancer informatics·2026
Same journal

Translating Data Into Clinical Tools: An Integrative Strategy for Precision Biomarker Identification in Soft Tissue Sarcoma Diagnosis and Prognosis.

Cancer informatics·2026
Same journal

The MAPK Pathway Coordinates an Immunosuppressive Microenvironment in Colorectal Cancer: A Single-Cell Guided Prognostic Model.

Cancer informatics·2026
Same journal

Multi-Scale Cross-Attention Multiple Instance Learning Network for Automated Classification of Colorectal Polyps.

Cancer informatics·2026
Same journal

LEPR Contributes to Lung Squamous Cell Carcinoma: Insights From Mendelian Randomization and Experimental Studies.

Cancer informatics·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K

A new method for predicting patient survivorship using efficient bayesian network learning.

Xia Jiang1, Diyang Xue1, Adam Brufsky2

  • 1Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA.

Cancer Informatics
|February 22, 2014
PubMed
Summary
This summary is machine-generated.

A new Bayesian network (BN) method, EBMC-Survivorship (EBMC_S), accurately predicts patient survivorship from high-dimensional data. This method offers enhanced clinical decision support and outperforms traditional models.

Keywords:
Bayesian networkCox proportional hazard modelbreast cancerrandom survival forestsurvivorship prediction

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Related Experiment Videos

Last Updated: May 2, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.1K

Area of Science:

  • Computational biology
  • Biostatistics
  • Machine learning in healthcare

Background:

  • Accurate patient survivorship prediction is crucial for clinical decision-making.
  • Existing methods may struggle with high-dimensional data common in cancer research.
  • Bayesian networks (BNs) offer a robust framework for complex data analysis and decision support.

Purpose of the Study:

  • To develop and evaluate a novel Bayesian network (BN)-based method for patient survivorship prediction.
  • To assess the method's capability in handling high-dimensional data.
  • To determine its suitability for integration into clinical decision support systems (CDSS).

Main Methods:

  • Development of EBMC-Survivorship (EBMC_S), utilizing the EBMC BN algorithm.
  • Evaluation using the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset.
  • Comparison with Cox proportional hazard model and random survival forest using 5-fold cross-validation.

Main Results:

  • EBMC-Survivorship (EBMC_S) demonstrates superior performance compared to the Cox proportional hazard model.
  • EBMC_S performance is comparable to the random survival forest method.
  • The method provides valuable insights, including covariate importance and yearly predictive accuracy (AUROCs).

Conclusions:

  • The developed Bayesian network (BN) method, EBMC-Survivorship (EBMC_S), effectively predicts patient survivorship.
  • The method successfully handles high-dimensional data and is suitable for clinical decision support.
  • Findings support the hypothesis that EBMC-S enhances survivorship prediction and clinical insights.